Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

National Institutes of Health

Federal funding opportunity PAR-25-266 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.